• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用每日日记卡的医学研究委员会生活质量研究——癌症试验中的实践经验教训。

MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials.

作者信息

Fayers P

机构信息

MRC Cancer Trials Office, Cambridge, UK.

出版信息

Qual Life Res. 1995 Aug;4(4):343-52. doi: 10.1007/BF01593887.

DOI:10.1007/BF01593887
PMID:7550183
Abstract

The UK Medical Research Council (MRC) Daily Diary Card for quality of life (QOL) assessment was first designed over ten years ago, and since then has been in continuous use in cancer clinical trials organized by the MRC Cancer Trials Office. However, clinical trials using this technique have only reached maturity since 1989 and later. Thus it is timely to review the experiences gained by use of this method of assessing QOL. Results from a series of clinical trials confirm that the Daily Diary Card appears to be a valid, reliable and sensitive instrument which is able to detect the transient changes in health and QOL which occur on a day to day basis during therapy for cancer. However, in early studies we also encountered a number of problems which were addressed during later MRC trials; we believe that many of these are of general importance to any investigation of QOL in patients, many of the issues raised remain controversial, and the practical lessons learned from applying the Diary Card will be of relevance to those planning future studies of QOL assessment.

摘要

英国医学研究理事会(MRC)用于生活质量(QOL)评估的每日日记卡于十多年前首次设计,从那时起一直在MRC癌症试验办公室组织的癌症临床试验中持续使用。然而,使用这种技术的临床试验直到1989年及以后才成熟。因此,及时回顾使用这种评估生活质量方法所获得的经验是很有必要的。一系列临床试验的结果证实,每日日记卡似乎是一种有效、可靠且敏感的工具,能够检测出癌症治疗期间每天出现的健康和生活质量的短暂变化。然而,在早期研究中我们也遇到了一些问题,这些问题在后来的MRC试验中得到了解决;我们认为其中许多问题对于任何患者生活质量调查都具有普遍重要性,许多提出的问题仍然存在争议,并且从应用日记卡中学到的实际经验教训将与那些计划未来生活质量评估研究的人相关。

相似文献

1
MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials.使用每日日记卡的医学研究委员会生活质量研究——癌症试验中的实践经验教训。
Qual Life Res. 1995 Aug;4(4):343-52. doi: 10.1007/BF01593887.
2
Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.临床试验中的生活质量评估——给方案撰写者的指南及清单:英国医学研究理事会的经验。英国医学研究理事会癌症试验办公室
Eur J Cancer. 1997 Jan;33(1):20-8. doi: 10.1016/s0959-8049(96)00412-1.
3
Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.小细胞肺癌化疗期间的生活质量:一项随机试验中日常日记卡的评估与应用
Eur J Cancer. 1990 Apr;26(4):484-92. doi: 10.1016/0277-5379(90)90022-l.
4
Validation of an asthma quality of life diary in a clinical trial.一项临床试验中哮喘生活质量日记的验证
Thorax. 1995 Jul;50(7):724-30. doi: 10.1136/thx.50.7.724.
5
The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW.使用SEIQoL-DW参与I期临床试验的癌症患者的生活质量。
J Adv Nurs. 1999 Aug;30(2):335-43. doi: 10.1046/j.1365-2648.1999.01079.x.
6
Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party.使用医学研究理事会肺癌工作组开发的每日日记卡评估小细胞肺癌患者的生活质量。
Br J Cancer. 1991 Aug;64(2):299-306. doi: 10.1038/bjc.1991.296.
7
Psychometric Properties of the Asthma Symptom Diary (ASD), a Diary for Use in Clinical Trials of Persistent Asthma.哮喘症状日记(ASD)的心理测量学特性,一种用于持续性哮喘临床试验的日记。
J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):60-6.e4. doi: 10.1016/j.jaip.2015.07.008. Epub 2015 Nov 6.
8
Reliability, validity and feasibility of quality of life instruments for adult patients with cancer undergoing chemotherapy: result from a systematic review.癌症化疗成人患者生命质量测评工具的信度、效度和可行性:系统评价结果。
Int J Evid Based Healthc. 2012 Mar;10(1):27-52. doi: 10.1111/j.1744-1609.2012.00252.x.
9
Quality of life in oncology trials: a clinical guide.肿瘤学试验中的生活质量:临床指南。
Semin Radiat Oncol. 2003 Jul;13(3):235-47. doi: 10.1016/S1053-4296(03)00029-8.
10
Quality of life instruments in oncology.肿瘤学中的生活质量评估工具
Eur J Cancer. 1999 Oct;35(11):1571-80. doi: 10.1016/s0959-8049(99)00193-8.

引用本文的文献

1
Inclusion in neurological research: empowering people living with neurological diseases.纳入神经学研究:增强神经疾病患者的权能。
Nat Rev Neurol. 2025 Mar;21(3):159-170. doi: 10.1038/s41582-024-01047-6. Epub 2025 Jan 7.
2
Yoga Practice Predicts Improvements in Day-to-Day Pain in Women With Metastatic Breast Cancer.瑜伽练习可改善转移性乳腺癌女性的日常疼痛。
J Pain Symptom Manage. 2021 Jun;61(6):1227-1233. doi: 10.1016/j.jpainsymman.2020.10.009. Epub 2020 Oct 14.
3
Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.

本文引用的文献

1
Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma.在开发一种针对哮喘的、与健康相关的生活质量量表时,访谈式问卷与自填式问卷的比较
J Clin Epidemiol. 1993 Jun;46(6):529-34. doi: 10.1016/0895-4356(93)90125-k.
2
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.欧洲癌症研究与治疗组织QLQ-C30:一种用于肿瘤学国际临床试验的生活质量评估工具。
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.
3
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
临床试验中的患者报告结局(PROs):是否缺乏“试验内”指导?一项系统评价。
PLoS One. 2013;8(4):e60684. doi: 10.1371/journal.pone.0060684. Epub 2013 Apr 1.
4
Symptom-monitoring behaviors of rural cancer patients and survivors.农村癌症患者及幸存者的症状监测行为
Support Care Cancer. 2009 Jun;17(6):617-26. doi: 10.1007/s00520-008-0552-8. Epub 2008 Dec 23.
5
Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials.评估临床实践中使用患者报告结局(PROs)的有效性:整群随机试验的作用。
Qual Life Res. 2008 Dec;17(10):1315-21. doi: 10.1007/s11136-008-9391-9. Epub 2008 Sep 27.
6
An assessment of the feasibility and utility of the MS symptom and impact diary (MSSID).对多发性硬化症症状与影响日记(MSSID)的可行性和实用性评估。
Qual Life Res. 2005 Jun;14(5):1363-74. doi: 10.1007/s11136-004-5389-0.
7
Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation.造血干细胞移植后基于网络的非常频繁的生活质量和症状家庭自我评估系统的开发、可行性及合规性
Qual Life Res. 2005 Feb;14(1):77-93. doi: 10.1007/s11136-004-2394-2.
8
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.多西他赛两种给药方案(每周一次与每三周一次)用于非小细胞肺癌二线治疗的随机临床试验。DISTAL 01研究。
Br J Cancer. 2004 Dec 13;91(12):1996-2004. doi: 10.1038/sj.bjc.6602241.
9
The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis.MS症状与影响日记(MSSID):一种用于测量多发性硬化症日常影响的新工具的心理测量评估
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):577-82. doi: 10.1136/jnnp.2003.020529.
晚期乳腺癌的联合化疗或轻度单药化疗?CMF方案与表柔比星方案对生活质量的影响比较
Br J Cancer. 1993 Feb;67(2):402-6. doi: 10.1038/bjc.1993.74.
4
A daily diary for quality of life measurement in advanced breast cancer trials.晚期乳腺癌试验中用于生活质量测量的每日日记。
Br J Cancer. 1993 Feb;67(2):341-6. doi: 10.1038/bjc.1993.62.
5
Generalizing the results of randomized clinical trials.归纳随机临床试验的结果。
Control Clin Trials. 1994 Feb;15(1):15-23. doi: 10.1016/0197-2456(94)90024-8.
6
Lessons learned from measuring health-related quality of life in oncology.肿瘤学中健康相关生活质量测量的经验教训。
J Clin Oncol. 1994 Mar;12(3):608-16. doi: 10.1200/JCO.1994.12.3.608.
7
Centralised treatment, entry to trials and survival.集中治疗、进入试验与生存情况。
Br J Cancer. 1994 Aug;70(2):352-62. doi: 10.1038/bjc.1994.306.
8
The roles of patient and observer assessments in anti-emetic trials.患者评估与观察者评估在止吐试验中的作用。
Eur J Cancer. 1994;30A(9):1223-7. doi: 10.1016/0959-8049(94)90162-7.
9
Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party.小细胞肺癌试验中与治疗相关的死亡:能否识别出有风险的患者?医学研究委员会肺癌工作组
Lung Cancer. 1994 Sep;11(3-4):259-74. doi: 10.1016/0169-5002(94)90546-0.
10
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.依托泊苷、环磷酰胺、甲氨蝶呤和长春新碱三疗程或六疗程与依托泊苷和异环磷酰胺六疗程治疗小细胞肺癌(SCLC)的随机试验。II:生活质量。医学研究委员会肺癌工作组
Br J Cancer. 1993 Dec;68(6):1157-66. doi: 10.1038/bjc.1993.497.